Bay Street News, November, 2019

TORONTO, Nov. 08, 2019 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: […]

SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development […]

Topline Data From Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Failed to Meet Primary EndpointReported Positive Topline […]

MADISON HEIGHTS, MICHIGAN, Nov. 08, 2019 (GLOBE NEWSWIRE) —  InfuSystem Holdings, Inc. (NYSE American: INFU), a leading national provider of […]

CAMBRIDGE, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on […]

NEW YORK, Nov. 08, 2019 (GLOBE NEWSWIRE) — Sequential Brands Group, Inc. (“Sequential” or the “Company”) (Nasdaq:SQBG) today announced financial […]

SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product […]

CALGARY, Alberta, Nov. 08, 2019 (GLOBE NEWSWIRE) — Kelt Exploration Ltd. (TSX:KEL) (“Kelt” or the “Company”) has released its financial and […]

SAN JOSE, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (OTCQX: POETF; TSX Venture: […]

HAMILTON, Ontario, Nov. 08, 2019 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a […]